Materia Malta has received the European Union Good Manufacturing Practices (“EU GMP”) certification from the Malta Medicines Authority. This certification will enable Materia to begin processing and exporting medical cannabis flower from Malta into end markets across Europe, following the final post-certification steps in accordance with the licensure process.
Materia Malta is the wholly owned subsidiary of Materia, a medical cannabis and wellness company focused on the European market.
EU GMP is the global gold standard for pharmaceutical production and a requirement for medical cannabis in most European jurisdictions. The company also intends to apply for a license amendment to process cannabis extracts imminently, leveraging the comprehensive preparatory work already completed.
“Becoming EU GMP certified in Malta represents our most significant milestone since we embarked on this project over two years ago. We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis processor to the industry, especially global partners seeking access to the European market”, says Deepak Anand, CEO of Materia.
"We are tremendously proud to join the small group of cannabis companies with an EU GMP-certified facility. Our team in Malta has been relentless in pursuit of this goal and adapted exceptionally to the circumstances of the last year, demonstrating why we consider them amongst the industry’s best. Having successfully developed our envisioned European infrastructure, commercialization now becomes our focus”, adds Nick Pateras, Managing Director, Europe of Materia.
"Materia Malta will utilize its network of qualified supply chain partners to introduce new, high quality medical cannabis to the European market, including into Germany through the pharmacy distribution channels of Materia Deutschland GmbH."